Consolidating and Managing Data for Drug Development within a Pharmaceutical Laboratory: Comparing the Mapping and Reporting Tools from Software Applications
- 14 September 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (10), 2177-2187
- https://doi.org/10.1021/acs.oprd.1c00082
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Laboratory Informatics Tools Integration Strategies for Drug Discovery: Integration of LIMS, ELN, CDS, and SDMSSLAS Technology, 2013
- Risk Assessment of Genotoxic Impurities in New Chemical Entities: Strategies To Demonstrate ControlOrganic Process Research & Development, 2013
- A facile synthesis of melatonergic antidepressant agomelatineTetrahedron Letters, 2012
- Carry Over of Impurities: A Detailed Exemplification for Glycopyrrolate (NVA237)Organic Process Research & Development, 2012
- A perspective on PSE in pharmaceutical process development and innovationComputers & Chemical Engineering, 2012
- A Tool for the Semiquantitative Assessment of Potentially Genotoxic Impurity (PGI) Carryover into API Using Physicochemical Parameters and Process ConditionsOrganic Process Research & Development, 2010
- Identification of Critical Process Impurities and Their Impact on Process Research and DevelopmentOrganic Process Research & Development, 2008
- Pharmaceutical impurities: Regulatory perspective for Abbreviated New Drug ApplicationsAdvanced Drug Delivery Reviews, 2007
- AgomelatineCNS Drugs, 2006
- Novel naphthalenic ligands with high affinity for the melatonin receptorJournal of Medicinal Chemistry, 1992